Literature DB >> 3524216

Aminoglycoside antibiotics in infectious diseases. An overview.

W E Siegenthaler, A Bonetti, R Luthy.   

Abstract

This article presents an overview of the aminoglycoside antibiotics used in clinical practice. Facts concerning the discovery and properties of the aminoglycosides are followed by information about spectrums of activity and mechanisms of action and resistance. Individual compounds are compared and proposals on the possibilities for their clinical use, both as single drugs and in combination with beta-lactam antibiotics, are made. The importance placed on measuring the serum concentrations of aminoglycoside antibiotics should serve as a remainder that this procedure is important, on one hand, to increase clinical efficacy and, on the other, to reduce the side effects of these antibiotics. Finally, the aminoglycosides are compared briefly with other antibacterial compounds, some of which are very new. There is no doubt that in the future the aminoglycosides will continue to occupy an important place in the treatment of severe infections, although newly developed agents appear to be effective complements.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524216     DOI: 10.1016/0002-9343(86)90473-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Aminoglycoside therapy: current and prospective uses.

Authors:  J E Leggett
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Aminoglycoside therapy. Current use and future prospects.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1990-06-22

3.  Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections.

Authors:  P J de Vries; R P Verkooyen; P Leguit; H A Verbrugh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

4.  Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides.

Authors:  J M Gatell; F Ferran; V Araujo; M Bonet; E Soriano; J Traserra; J G SanMiguel
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 5.  Biosynthesis of unusual aminocyclitol-containing natural products.

Authors:  Taifo Mahmud; Patricia M Flatt; Xiumei Wu
Journal:  J Nat Prod       Date:  2007-07-28       Impact factor: 4.050

Review 6.  Biosafety of kanamycin-resistant transgenic plants.

Authors:  J P Nap; J Bijvoet; W J Stiekema
Journal:  Transgenic Res       Date:  1992-11       Impact factor: 2.788

7.  Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa.

Authors:  A Omri; C Beaulac; M Bouhajib; S Montplaisir; M Sharkawi; J Lagacé
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

8.  Shifts in auditory brainstem response latencies following plasma-level-controlled aminoglycoside therapy.

Authors:  M A Hotz; J H Allum; G Kaufmann; F Follath; C R Pfaltz
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

9.  Salicylic acid attenuates gentamicin-induced nephrotoxicity in rats.

Authors:  Pavle Randjelovic; Slavimir Veljkovic; Nenad Stojiljkovic; Ljubinka Jankovic-Velickovic; Dusan Sokolovic; Milan Stoiljkovic; Ivan Ilic
Journal:  ScientificWorldJournal       Date:  2012-04-30

10.  Acquired antibiotic resistance genes: an overview.

Authors:  Angela H A M van Hoek; Dik Mevius; Beatriz Guerra; Peter Mullany; Adam Paul Roberts; Henk J M Aarts
Journal:  Front Microbiol       Date:  2011-09-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.